All In the Family: Sergey Brin Loans 23andme $10 Million And Google Ponies Up $2.6 Million

Leena Rao

Leena Rao is currently a Senior Editor for TechCrunch. She recently finished graduate school at the Medill School of Journalism at Northwestern University, where she studied business journalism and videography. From 2004 to 2007, she helped lead Congresswoman Carloyn Maloney’s community outreach and relations efforts in New York City. She graduated from Columbia University in 2003, where she was... → Learn More

Thursday, June 18th, 2009

Google is still tightly intertwined with 23andme, a company that helps consumers understand and decipher their genomes. 23andme has raised another $2.6 million from Google out of a total $24.26 million it is trying to raise in a Series B round of funding, according to regulatory filings. This brings the total amount raised from this round to $13.6 million, after May’s $11 million funding round. At the time, Mohr Davidow Ventures divested its stake in 23andme after investing in a direct competitor Navigenics.

The juiciest disclosure in the filing is that Brin loaned the startup an additional $10 million which is being converted into Series B preferred shares. Earlier in 2007, he had loaned the company $2.6 million which was repaid from the proceeds of Google’s subsequent $3.9 million stake in 23andMe in May, 2007. The debt was repaid after the Google investment. It appears that Brin once again had to dig into his own pocket to help keep the company afloat.

The filing also says one of the investors in the Series B round in May was New Enterprise Associates, which also invested in 23andme’s Series A round. And it mentions that Google has entered into a lease agreement with 23andme, possibly for office space, but it is unclear what exactly is being leased.

23andme, which was co-founded by Sergey Brin’s wife, Anne Wojcicki, raised $9 million in a Series A round of funding from Google, Genentech, New Enterprise Associates, and Mohr Davidow Ventures in 2007. The company maps consumers’ DNA and helps them find information about their ancestry and their risks of getting certain diseases (Michael tried it last year).

blog comments powered by Disqus